Department of Neurology, Hunan Children's Hospital, Ziyuan Road & No. 86, Changsha, 410001, Hunan, China.
Neurol Sci. 2022 Aug;43(8):5039-5048. doi: 10.1007/s10072-022-06038-3. Epub 2022 Mar 29.
Developmental and epileptic encephalopathy (DEE) exhibits phenotypic and genetic heterogeneity. Biallelic variants of the SZT2 gene can lead to DEE18, of which few cases have been reported. This study aimed to analyze the potential pathogenic factors in three cases of DEE18.
Trio-whole exome sequencing and crystal structure simulation analysis were performed, along with a literature review of DEE18 cases.
All three patients had compound heterozygous variants in the SZT2 gene (patient 1, c.2887A > G/c.7970G > A; patient 2, c.3508A > G/c.7936C > T; and patient 3, c.2489G > T/c.8640_8641insC). The variants were predicted to have structural effects on the protein. Particularly, c.3508A > G/p.Ser1170Gly may lead to impaired binding of SZT2 to GATOR1, potentially resulting in the overactivation of the mTORC1 signaling pathway, causing seizures. Through the literature review, we observed that 27 patients with DEE had different degrees of intellectual and developmental disorders (DDs), and the variants leading to protein truncation cause severe DD and refractory epilepsy. Therefore, the phenotypic severity of patients may be related to the residual activity of variant SZT2 protein.
We provide recently developed knowledge on the DEE18 genotype-phenotype spectrum and suggest that gene detection is of great value for the accurate diagnosis of patients with early-onset epilepsy. Further research is required for the development of individualized interventions for patients with DEE.
发育性和癫痫性脑病(DEE)表现出表型和遗传异质性。SZT2 基因的双等位基因突变可导致 DEE18,目前报道的病例较少。本研究旨在分析 3 例 DEE18 的潜在致病因素。
进行了三亲子全外显子组测序和晶体结构模拟分析,并对 DEE18 病例进行了文献回顾。
所有 3 名患者均在 SZT2 基因中存在复合杂合变异(患者 1:c.2887A>G/c.7970G>A;患者 2:c.3508A>G/c.7936C>T;患者 3:c.2489G>T/c.8640_8641insC)。这些变异被预测对蛋白质具有结构影响。特别是,c.3508A>G/p.Ser1170Gly 可能导致 SZT2 与 GATOR1 的结合受损,从而可能导致 mTORC1 信号通路过度激活,引发癫痫发作。通过文献回顾,我们观察到 27 例 DEE 患者存在不同程度的智力和发育障碍(DD),导致蛋白截短的变异会引起严重的 DD 和难治性癫痫。因此,患者的表型严重程度可能与变异 SZT2 蛋白的残留活性有关。
我们提供了 DEE18 基因型-表型谱的最新知识,并建议基因检测对于早期发作性癫痫患者的准确诊断具有重要价值。需要进一步研究以制定针对 DEE 患者的个体化干预措施。